SANUWAVE HealthSNWV -1.22%38 Days Payable is 136.02 as of Mar. 2026, which is 71% below its 10-year median of 475.17. GuruFocus rates SNWV with a GF Score™ of 38/100 and a GF Value™ of $11.96 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 795 Medical Devices & Instruments companies, SANUWAVE Health ranks better than 74.59% on this metric.
The historical rank and industry rank for SANUWAVE Health's Days Payable or its related term are showing as below:
SNWV'
s Days Payable Range Over the Past 10 Years
Min: 124.96 Med: 475.17 Max: 1666.63
Current: 132.15
During the past 13 years, SANUWAVE Health's highest Days Payable was 1666.63. The lowest was 124.96. And the median was 475.17.
SNWV's Days Payable is ranked better than 74.59% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs SNWV: 132.15
SANUWAVE Health's Days Payable
declined
from Mar. 2025 (182.57) to Mar. 2026 (136.02).
It may suggest that SANUWAVE Healthaccelerated paying its suppliers.
SANUWAVE Health Days Payable Related Terms
SANUWAVE Health Days Payable Historical Data
* Premium members only.
The historical data trend for SANUWAVE Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SANUWAVE Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Days Payable distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
SANUWAVE Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SANUWAVE Health (SNWV) has a Days Payable of 136.02 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SANUWAVE Health and its competitors. This is 71% below median its historical median of 475.17. Over the past decade, SANUWAVE Health's Days Payable has ranged from 124.96 to 1,666.63. According to the industry distribution chart, SANUWAVE Health ranks #202 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 25.4%.
Is SANUWAVE Health's Days Payable too high?
SANUWAVE Health's current Days Payable of 136.02 is 71% below median its 10-year median of 475.17. Over the past 10 years, this metric has ranged from a low of 124.96 to a high of 1,666.63. The Medical Devices & Instruments industry median Days Payable is 68.07. SANUWAVE Health's value of 136.02 is 99.8% above this industry median. Based on the distribution chart, SANUWAVE Health ranks #202 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, SANUWAVE Health has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's Days Payable compare to RTGN and NNOX?
According to the Medical Devices & Instruments industry distribution chart, SANUWAVE Health ranks #202 out of 795 companies for Days Payable. This puts SANUWAVE Health in the upper half of its industry. The industry median Days Payable is 68.07. SANUWAVE Health's value of 136.02 is 99.8% above this benchmark. Historically, SANUWAVE Health's own Days Payable has ranged from 124.96 to 1,666.63 over the past decade. While the company's 10-year median is 475.17 vs. the industry median of 68.07, SANUWAVE Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SANUWAVE Health's current Days Payable of 136.02 is 99.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SANUWAVE Health and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SANUWAVE Health's current Days Payable is 136.02, which is 71% below median its own 10-year median of 475.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.96, compared to a current price of $10.50 — trading 12.2% below its estimated fair value. The current Days Payable is 136.02, which is 71% below median its 10-year median of 475.17 and 99.8% above the Medical Devices & Instruments industry median of 68.07. SANUWAVE Health's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current Days Payable is 136.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SANUWAVE Health (SNWV) Overvalued in 2026?
Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued.
The current stock price of $10.50 is trading 12.2% below its estimated GF Value™ of $11.96.
GuruFocus considers SANUWAVE Health to be Modestly Undervalued.
Key valuation signals for SNWV:
Days Payable: 136.02 (71% below median its 10-year median of 475.17)
GF Value™: $11.96 vs. price of $10.50 (12.2% below fair value)
Industry Position: 99.8% above the Medical Devices & Instruments median (#202 of 795)
No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
38GF Score
Get the complete analysis for SNWV
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNWV has been successfully added to your 
